Literature DB >> 20095999

Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis.

C Becattini1, M C Vedovati, W Ageno, F Dentali, G Agnelli.   

Abstract

SUMMARY
BACKGROUND: Whether patients with unprovoked venous thromboembolism (VTE) have a higher risk of arterial cardiovascular events than the general population and patients with provoked VTE is a matter of debate.
OBJECTIVE: To perform a systematic review and a meta-analysis aimed at assessing the risk of arterial cardiovascular events in patients with unprovoked VTE as compared with both patients with provoked VTE and controls.
METHODS: A systematic search was performed. Studies reporting on (i) patients with confirmed VTE, (ii) a follow-up of at least 6 months and (iii) the incidence of arterial cardiovascular events (acute myocardial infarction and ischemic stroke) were included in the systematic review. Those studies reporting separate incidences of cardiovascular events in patients with unprovoked and provoked VTE or patients with unprovoked VTE and controls were included in the incidence rate meta-analysis.
RESULTS: Overall, 17 studies were included in the systematic review. The weighted mean incidence of arterial cardiovascular events was 0.46% [95% confidence interval (CI) 0.34-0.59] and 0.35% (95% CI 0.24-0.49) per patient-year in patients with unprovoked and provoked VTE, respectively. Six studies were included in the meta-analysis. The risk of arterial cardiovascular events appeared to be higher in patients with unprovoked VTE than in controls [incidence rate ratio (IRR) 1.87, 95% CI 1.32-2.65] and than in patients with provoked VTE (IRR 1.86, 95% CI 1.19-2.89).
CONCLUSIONS: Patients with unprovoked VTE have a higher risk of arterial cardiovascular events than patients with provoked VTE over long-term follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 20095999     DOI: 10.1111/j.1538-7836.2010.03777.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  16 in total

1.  Arterial cardiovascular events and mortality following venous thromboembolism.

Authors:  Kasper Adelborg; Jens Sundbøll; Henrik Toft Sørensen
Journal:  Ann Transl Med       Date:  2015-06

2.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

3.  Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Monika Sznajder; Olga Dzikowska-Diduch; Katarzyna Kurnicka; Marek Roik; Dominik Wretowski; Piotr Pruszczyk; Maciej Kostrubiec
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

Review 4.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

Review 5.  Epidemiology, risk factors and management of cardiovascular diseases in IBD.

Authors:  Siddharth Singh; Iftikhar J Kullo; Darrell S Pardi; Edward V Loftus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

6.  Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies.

Authors:  Michel K Barsoum; Kevin P Cohoon; Véronique L Roger; Ramila A Mehta; David O Hodge; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2014-07-05       Impact factor: 3.944

7.  Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis.

Authors:  Walter Ageno; Matteo N D Di Minno; Cihan Ay; Moon Ju Jang; John-Bjarne Hansen; Lyn M Steffen; Amparo Vayà; Marcello Rattazzi; Ingrid Pabinger; Doyeun Oh; Giovanni Di Minno; Sigrid K Braekkan; Mary Cushman; Elena Bonet; Paolo Pauletto; Alessandro Squizzato; Francesco Dentali
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-11       Impact factor: 8.311

8.  Arterial and venous thrombosis in cancer patients.

Authors:  Andrew D Blann; Simon Dunmore
Journal:  Cardiol Res Pract       Date:  2011-03-03       Impact factor: 1.866

9.  Recurrent arterial and venous thromboemboli as initial presentation of acute promyelocytic leukemia.

Authors:  Felix Trottier-Tellier; Madeleine Durand; Christophe Kolan; Robert Wistaff; Paul Van Nguyen; Mikhael Laskine
Journal:  J Clin Med Res       Date:  2014-07-28

10.  Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy.

Authors:  Philip S Wells; Martin Gebel; Martin H Prins; Bruce L Davidson; Anthonie Wa Lensing
Journal:  Thromb J       Date:  2014-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.